Amarin Corporation PLC (AMRN) - Total Liabilities
Based on the latest financial reports, Amarin Corporation PLC (AMRN) has total liabilities worth $196.35 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Amarin Corporation PLC - Total Liabilities Trend (1993–2025)
This chart illustrates how Amarin Corporation PLC's total liabilities have evolved over time, based on quarterly financial data. See AMRN net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Amarin Corporation PLC Competitors by Total Liabilities
The table below lists competitors of Amarin Corporation PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kendrion NV
AS:KENDR
|
Netherlands | €120.50 Million |
|
DITTO (THAILAND)
BK:DITTO-R
|
Thailand | ฿1.10 Billion |
|
Wuhu Conch Profiles and Science Co Ltd
SHE:000619
|
China | CN¥2.42 Billion |
|
Guangzhou Jointas Chemical Joint Stock Co Ltd
SHE:002909
|
China | CN¥1.41 Billion |
|
BIDV Securities JSC
VN:BSI
|
Vietnam | ₫11.10 Trillion |
|
Ioneer Ltd
AU:INR
|
Australia | AU$3.24 Million |
|
Heung-A Shipping Co. Ltd.
KO:003280
|
Korea | ₩193.05 Billion |
|
Huizhong Instrumentation Co Ltd
SHE:300371
|
China | CN¥107.14 Million |
Liability Composition Analysis (1993–2025)
This chart breaks down Amarin Corporation PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Amarin Corporation PLC (AMRN) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Amarin Corporation PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Amarin Corporation PLC (1993–2025)
The table below shows the annual total liabilities of Amarin Corporation PLC from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $211.49 Million | +6.19% |
| 2024-12-31 | $199.17 Million | -28.76% |
| 2023-12-31 | $279.59 Million | -3.87% |
| 2022-12-31 | $290.85 Million | -27.46% |
| 2021-12-31 | $400.97 Million | +18.45% |
| 2020-12-31 | $338.52 Million | +23.57% |
| 2019-12-31 | $273.95 Million | +17.38% |
| 2018-12-31 | $233.38 Million | +2.95% |
| 2017-12-31 | $226.70 Million | +28.76% |
| 2016-12-31 | $176.06 Million | -41.83% |
| 2015-12-31 | $302.65 Million | +16.60% |
| 2014-12-31 | $259.56 Million | -9.35% |
| 2013-12-31 | $286.33 Million | -9.06% |
| 2012-12-31 | $314.85 Million | +137.91% |
| 2011-12-31 | $132.34 Million | -44.33% |
| 2010-12-31 | $237.73 Million | +3030.14% |
| 2009-12-31 | $7.59 Million | -2.11% |
| 2008-12-31 | $7.76 Million | -57.14% |
| 2007-12-31 | $18.11 Million | +64.73% |
| 2006-12-31 | $10.99 Million | +34.36% |
| 2005-12-31 | $8.18 Million | +16.39% |
| 2004-12-31 | $7.03 Million | -86.92% |
| 2003-12-31 | $53.73 Million | -48.22% |
| 2002-12-31 | $103.75 Million | +69.17% |
| 2001-12-31 | $61.33 Million | +251.88% |
| 2000-12-31 | $17.43 Million | -19.21% |
| 1999-12-31 | $21.57 Million | -28.10% |
| 1998-12-31 | $30.00 Million | +17.65% |
| 1997-12-31 | $25.50 Million | +18.06% |
| 1996-12-31 | $21.60 Million | +222.39% |
| 1995-12-31 | $6.70 Million | +13.56% |
| 1993-12-31 | $5.90 Million | -- |
About Amarin Corporation PLC
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The compa… Read more